Towards Healthcare

Sequential Compression System Market Development Challenges in Animal Dermatology Treatments

According to our projections, the sequential compression system market was valued at USD 1.3 billion in 2025 and is projected to reach USD 1.41 billion in 2026, expanding to approximately USD 2.9 billion by 2035, growing at a CAGR of 8.37% from 2026 to 2035.

Last Updated : 13 March 2026 Category: Medical Devices Insight Code: 6751 Format: PDF / PPT / Excel
Revenue, 2025
USD 1.3 Billion
Forecast, 2035
USD 2.9 Billion
CAGR, 2026-2035
8.37%
Report Coverage
Global

The global sequential compression system market size was estimated at USD 1.3 billion in 2025 and is predicted to increase from USD 1.41 billion in 2026 to approximately USD 2.9 billion by 2035, expanding at a CAGR of 8.37% from 2026 to 2035.

Sequential Compression System Market Size is USD 1.41 Billion in 2026.

The market is expanding due to the rising prevalence of circulatory disorders and increasing surgical procedures. Growing awareness of thrombosis prevention, improvements in medical device technology, and higher adoption in hospitals and home healthcare are supporting market growth.

Key Takeaways

  • Sequential compression system sector pushed the market to USD 1.41 billion by 2026.
  • Long-term projections show USD 2.9 billion valuation by 2035.
  • Growth is expected at a steady CAGR of 8.37% in between 2026 to 2035.
  • North America dominated the sequential compression system market by 39% in 2025.
  • Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.
  • By product, the consumables & accessories segment dominated the market in 2025.
  • By product, the compression systems segment is expected to grow at the fastest CAGR in the market during the forecast period.
  • By technology, the simultaneous sequential compassion (SSC) segment holds a dominant position in the market in 2025.
  • By technology, the alternate sequential compression (ASC) segment is expected to grow at the fastest CAGR in the market during the forecast period.
  • By application, the deep vein thrombosis (DVT) prevention segment registered dominance in the market in 2025. 
  • By application, the sports recovery & performance segment is expected to grow at the fastest CAGR in the sequential compression system market during the forecast period.
  • By end use, the institutional settings segment led the market in 2025.
  • By end use, the home & retail segment is expected to grow at the fastest CAGR in the market during the forecast period.

Rising Demand for Effective Circulation Therapy Driving Market Growth

Sequential compression systems are medical devices that use inflatable sleeves to apply controlled pressure to the limbs, improving blood circulation and helping prevent conditions such as blood clots and swelling. The sequential compression system market is expanding due to the growing number of surgical procedures and the increasing prevalence of venous disorders, such as deep vein thrombosis. Greater awareness about thrombosis prevention, along with the rising elderly population, is boosting product adoption. In addition, advancements in portable and user-friendly devices and the expanding use of home healthcare solutions are further supporting market growth.

Surgical Procedures No. of Surgeries Occurred
Orthopedic Surgical Procedures 30.5 Million
General Surgeries 75 Million
Cardiovascular Surgical Procedures 24 Million

How Can AI Revolutionize the Sequential Compression System Market?

Artificial intelligence can transform the market by enabling smarter and more personalized therapy. AI-powered devices can monitor patient circulation, adjust compression levels automatically, and provide real-time data to healthcare providers. This improves treatment effectiveness and patient safety. In addition, AI-driven analytics can help detect risks of blood clots early, support remote patient monitoring, and enhance device performance through predictive maintenance and usage insights.

  • Adoption of Smart and Digital Compression Systems: Manufacturers are increasingly integrating digital features such as sensors and connectivity into compression devices. These smart systems help track therapy progress, improve treatment accuracy, and allow healthcare professionals to monitor patient conditions more effectively, supporting better clinical outcomes.
  • Rising Preference for Portable and Home-Use Devices: The demand for compact and easy-to-use compression systems is increasing as healthcare gradually shifts toward home-based treatment. Portable devices allow patients to continue therapy after hospital discharge, improving convenience and supporting long-term care management.
  • Expanding Use in Multiple Medical Conditions: Sequential compression systems are being used beyond post-surgical clot prevention, including lymphedema management and rehabilitation therapies services. This broader range of medical applications is expected to increase product demand and create new opportunities for market growth in the future.

Executive Summary Table

Table Scope
Market Size in 2026 USD 1.41 Billion
Projected Market Size in 2035 USD 2.9 Billion
CAGR (2026 - 2035) 8.37%
Leading Region North America by 39%
Historical Data 2020 - 2023
Base Year 2025
Forecast Period 2026 - 2035
Measurable Values USD Millions/Units/Volume
Market Segmentation By Product, By Technology, By Application, By End Use, By Region
Top Key Players Cardinal Health, Arjo, Tactile Medical, Bio Compression Systems, Enovis, Mego Afek, Zimmer Biomet, AIROS Medical

Segmental Insights

By Product Insights 

Why Did the Consumables & Accessories Segment Dominate in the Market in 2025?

The consumables & accessories segment dominated the sequential compression system market in 2025 due to the frequent replacement of items such as compression sleeves, garments, and tubing. These components are for single-patient use or require regular replacements for hygiene and effectiveness. Additionally, the growing number of surgical procedures and hospital admissions increased the demand for these recurring products, making them a major revenue contributor in the market.

Compression Systems

The compression systems segment is expected to grow at the fastest CAGR due to increasing demand for advanced medical devices that provide effective prevention of deep vein thrombosis and improved blood circulation. Hospitals and home-care settings are adopting technologically advanced and portable compression systems to enhance patient comfort, support post-surgical recovery, and enable continuous therapy, which is accelerating segment growth during the forecast period.

By Technology Insights

Which Technology was Dominant in the Market in 2025?

The simultaneous sequencing compression (SSC) segment dominated the sequential compression system market in 2005 due to its ability to deliver uniform and efficient pressure across multiple chambers at the same time. This technology improves blood circulation more effectively and reduces the risk of clot formation. Its reliability, faster therapy cycles, and wider adoption in hospitals for post-surgical care and thrombosis prevention significantly contributed to its leading market share.

Alternate Sequential Compression (ASC)

The alternate sequential compression (ASC) segment is expected to grow at the fastest CAGR due to its ability to provide more controlled and consistent pressure therapy, improving blood flow and reducing the risk of clot formation. Increasing adoption of advanced compression technologies, rising surgical procedures, and growing demand for efficient thrombosis prevention in hospitals and home-care settings are the major factors supporting the rapid growth of the segment.

By Application Insights

How Does the Deep Vein Thrombosis (DVT) Prevention Segment Dominate the Sequential Compression System Market in 2025?

The deep vein thrombosis (DVT) prevention segment dominated the market in 2025 due to the high risk of blood clot formation among patients undergoing surgery, prolonged hospitalization, or limited mobility. Healthcare providers widely use these systems to improve blood circulation and reduce clot-related complications. Increasing awareness of thrombosis prevention and the growing number of surgical procedures further strengthened the segment’s leading position in the market.

Sports Recovery & Performance

The sports recovery & performance segment is expected to grow at the fastest CAGR due to the increasing adoption of compression therapy by athletes for recovery. Rising participation in sports and fitness activities, along with growing awareness about advanced recovery technologies, is driving demand. Additionally, portable and easy-to-use compression devices are encouraging their use in training centers and home settings.

By End-Use Insights

How Did the Institutional Settings Segment Dominate the Sequential Compression System Market in 2025?

The institutional settings segment dominated the market in 2025 due to the high number of surgical procedures and patient admissions in hospitals and clinics. These healthcare facilities widely use compression systems to prevent deep vein thrombosis in immobile or postoperative patients. Additionally, better access to advanced medical equipment, trained professionals, and established treatment protocols in institutional settings further supported the segment’s leading market share.

Home & Retail

The home & retail segment is expected to grow at the fastest CAGR due to the rising preference for home-based healthcare and convenient treatment options. Increasing awareness of compression therapy, growing availability of portable and user-friendly devices, and expanding online and retail distribution channels are encouraging patients to adopt these systems at home, particularly for long-term care, recovery, and preventive therapy.

Regional Insights

Sequential Compression System Market Shares for North America, Europe, Asia Pacific, Latin America and Middle East and Africa, 2025 (%).

Regions Share 2025 (%)
North America 39%
Europe 27%
APAC 24%
Latin America 6%
Middle East and Africa 4%

Strong Healthcare Infrastructure Driving Market Leadership in North America

North America dominated the sequential compression system market by 39% due to its advanced healthcare infrastructure and high adoption of medical technologies. The region also reports a large number of surgical procedures and cases of deep vein thrombosis, increasing the demand for preventive therapies. Additionally, the strong presence of leading medical device companies, supportive reimbursement policies, and growing awareness about thrombosis prevention further contributed to the region's market dominance.

U.S. Market Trends

The U.S. sequencing compression system market is leading due to the high number of surgical procedures and a strong focus on preventive deep vein thrombosis in hospitals. Advanced healthcare facilities and early adoption of innovative medical technologies further support market growth. Additionally, the presence of major medical device manufacturers, increasing awareness about circulatory health, and well-established healthcare spending contribute to the country’s dominant position in the market.

Rapid Healthcare Expansion Fueling Sequential Compression System Market Growth in the Asia Pacific

Asia Pacific is anticipated to grow at the fastest CAGR due to improving healthcare infrastructure, increasing healthcare expenditure, and rising awareness about thrombosis prevention. The growing number of surgeries, the expanding aging population, and the increasing adoption of advanced medical devices are also contributing to market growth. Additionally, developing countries in the region are investing more in hospital facilities and medical technologies, creating strong growth opportunities.

India Market Trends

India is expected to grow at the fastest CAGR in the sequential compression systems market due to expanding healthcare infrastructure and increasing investment in advanced medical technologies. The rising number of surgeries, growing awareness about deep thrombosis prevention, and improving access to hospital care are driving demand. Additionally, the country's large patient population and rapid development of private healthcare facilities are further supporting strong market growth.

Growing Focus on Preventive Healthcare Driving Market Growth in Europe

Europe is anticipated to grow at a notable rate in the sequential compression system market due to increasing awareness of deep vein thrombosis prevention and strong healthcare systems. The region also has a rising elderly population and a high number of surgical procedures. In addition, supportive healthcare policies, technological advancements in medical devices, and the presence of established healthcare providers are contributing to steady market growth.

UK Market Trends

The UK is expected to grow at a significant rate in the sequential compression system market due to increasing awareness about deep vein thrombosis prevention and improved patient care practices. The rising number of surgical procedures and a growing elderly population are also driving demand. Additionally, strong healthcare infrastructure, supportive clinical guidelines, and the adoption of advanced medical technologies are further contributing to market growth during the forecast period.

Supply Chain Analysis

R&D

  • Research and development in sequential compression systems (SCS) is increasingly focused on developing portable, smart, and wearable devices instead of traditional, stationary hospital equipment. These innovations aim to improve patient comfort, increase treatment adherence, and enhance clinical outcomes in the prevention of deep vein thrombosis (DVT).
  • Key players: Cardinal Health, Medtronic, DJO Global, and Arjo.

Clinical Trials

  • Clinical trials studies on sequential compression devices (SCDs) mainly evaluate their effectiveness in preventing venous thromboembolism and reducing edema. Recent trials are also exploring wearable and battery-powered compression devices designed to enhance patient comfort and improve treatment adherence.
  • Key players: Bio Compression Systems, Devon Medical Products, NormaTec, and AIROS Medical.

Patient Support and Services

Sequential compression devices (SCDs), also known as intermittent pneumatic compression systems, are used to improve blood circulation in the legs and help prevent conditions such as deep vein thrombosis and pulmonary embolism in patients with limited mobility. Support services focus on proper device usage, patient monitoring, and ensuring effective therapy, especially during post-surgical recovery. Key players: Zimmer Biomet, Breg Inc., Talley Group Ltd, and Mego Afek.

Top Vendors in the Sequential Compression System Market & Their Offerings

Sequential Compression System Market Companies Cardinal Health, Arjo, Tactile Medical, Bio Compression Systems, Enovis, Mego Afek

Companies Headquarters Offerings
Cardinal Health Ohio, USA Develops sequential compression devices and disposable compression sleeves designed to support blood circulation and help reduce the risk of blood clots in hospitalized or post-surgical patients.
Arjo Sweden Provides intermittent pneumatic compression systems and patient mobility solutions that assist healthcare providers in preventing circulatory complications in immobile patients.
Tactile Medical Minnesota, USA Offers advanced pneumatic compression therapy systems mainly used for managing lymphedema and other circulation-related conditions in clinical and home-care settings
Bio Compression Systems Pennsylvania, USA Manufactures pneumatic compression pumps and garments designed to improve lymphatic and venous circulation and support edema management.
Enovis Delaware, USA Through its rehabilitation and recovery product portfolio, the company provides compression therapy technologies used in post-surgical care and circulatory health management.
Mego Afek Israel Produces compression therapy systems such as pneumatic devices designed to treat lymphedema and support improved blood and lymphatic flow.
Zimmer Biomet Indiana, USA Supplies surgical care and recovery technologies, including compression solutions used to help prevent circulatory complications after orthopedic procedures.
AIROS Medical Pennsylvania, USA Develops pneumatic compression devices that assist in improving blood and lymph circulation and reducing swelling associated with vascular and lymphatic disorders.

SWOT Analysis

Strengths

  • Helps improve blood circulation and reduce the risk of deep vein thrombosis in immobile or post-surgical patients.
  • Provides a non-invasive and drug-free therapy option.
  • Widely used in hospitals, surgical centers, and rehabilitation facilities.
  • Ongoing technological advancements are leading to more portable and more user-friendly devices.

Weaknesses

  • The high cost of advanced compression systems can limit adoption.
  • Requires correct usage and monitoring for effective therapy.
  • Limited awareness in some developing healthcare markets.
  • Some patients may experience discomfort during long-term use.

Opportunities

  • Increasing demand for home-based healthcare solutions.
  • A growing elderly population prone to circulatory disorders.
  • Development of smart, wearable, and connected compression devices.
  • Expanding applications in sports recovery and rehabilitation.

Threats

  • Availability of alternative treatments such as anticoagulant medications.
  • Strict regulatory approval processes for medical devices.
  • Intense competition among medical device manufacturers.
  • Budget constraints in healthcare systems may affect adoption.

Recent Developments in the Sequential Compression System Market

  • In October 2025, ManaMed received U.S. Food and Drug Administration 510(k) clearance for its PlasmaFlow X sequential compression system. The device is a compact, tubeless system designed to support patient recovery. As a Class II medical device, it includes smart features, improved portability, and longer battery performance, allowing convenient and efficient compression therapy.
  • In November 2024, Cardinal Health introduced the Kendall SCD SmartFlow Compression System in the U.S. as a new addition to its compression therapy portfolio. The system uses advanced intermittent pneumatic compression technology to improve blood circulation in high-risk patients. It is designed to help prevent venous thromboembolism while also enhancing patient comfort and supporting healthcare providers with a more efficient treatment process.

Segments Covered in the Report

By Product

  • Compression Systems
    • Stationary/Tabletop Units
    • Portable & Wearable Units
  • Consumables & Accessories
    • Compression Sleeves
    • Garments
    • Replacement Tubing & Connectors

By Technology

  • Alternate Sequential Compression (ASC)
  • Simultaneous Sequential Compression (SSC)

By Application

  • Deep Vein Thrombosis (DVT) Prevention
  • Lymphedema Management
  • Chronic Venous Insufficiency (CVI) & Ulcer Management
  • Sports Recovery & Performance
  • Others

By End Use

  • Institutional Settings
    • Hospitals
    • Specialty Clinics
    • Rehabilitation & Skilled Nursing Facilities
  • Home & Retail
    • Home Healthcare
    • Direct-to-Consumer (DTC) Sports/Fitness Centers

By Region

  • North America
    • U.S.
    • Canada 
    • Mexico 
    • Rest of North America
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Europe 
    • Western Europe 
      • Germany 
      • Italy
      • France
      • Netherlands
      • Spain
      • Portugal 
      • Belgium
      • Ireland
      • UK 
      • Iceland 
      • Switzerland
      • Poland
      • Rest of Western Europe
    • Eastern Europe 
      • Austria
      • Russia & Belarus 
      • Türkiye
      • Albania 
      • Rest of Eastern Europe 
  • Asia Pacific
    • China 
    • Taiwan
    • India 
    • Japan 
    • Australia and New Zealand
    • ASEAN Countries (Singapore, Malaysia)
    • South Korea 
    • Rest of APAC 
  • MEA 
    • GCC Countries
      • Saudi Arabia 
      • United Arab Emirates (UAE)
      • Qatar 
      • Kuwait 
      • Oman 
      • Bahrain 
    • South Africa
    • Egypt 
    • Rest of MEA

FAQ's

Finding : The sequential compression system market is expected to grow steadily, increasing from USD 1.41 billion in 2026 to around USD 2.9 billion by 2035, at a CAGR of 8.37%

Finding : North America is currently leading the sequential compression system market by 39% due to its advanced healthcare infrastructure and high adoption of medical technologies.

Finding : The market includes several established medical device manufacturers such as Cardinal Health, Arjo, Tactile Medical, Bio Compression Systems, Enovis, Mego Afek, Zimmer Biomet, and AIROS Medical.

Tags

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar

Related Reports

Sequential Compression System Market
Updated Date: 13 March 2026   |   Report Code: 6751
WhatsApp